Bimekizumab trials for Psoriasis

All Bimekizumab trials · All Psoriasis trials

Phase breakdown

Recruiting trials studying Bimekizumab for Psoriasis

• A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
  NCT06888193 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Female · 14 locations
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
  NCT07219420 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 91 locations
• Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
  NCT06742333 · Phase: Phase 2 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 7 locations
• Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
  NCT06786936 · Phase: Not specified · Ages: 18 Years to 74 Years · Sex: All (male and female) · 2 locations
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
  NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Bimekizumab for Psoriasis?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.